Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Gynecol Oncol. 2013 Apr 8;130(1):213–218. doi: 10.1016/j.ygyno.2013.04.002

Table 5.

Perioperative outcomes: A. AL cases vs. controls; B. Stoma vs. no stoma patients

A.
Factor Cases (n=42) Controls (n=84) P-value*
LOS in days (median, range) 19.5 (5–84) 9.5 (4–36) <0.001
Unplanned ICU admission 15 (35.7%) 10 (11.9%)
OR=4.79, 95% CI 1.70–13.48 0.003
Ability to start chemotherapy 29/41 (70.7%) 69/75 (92%)
OR=0.31, 95% CI 0.11–0.83 0.020
TTC ≤30 days 5/41 (12.2%) 25/72 (34.7%) 0.027
OR=0.28, 95% CI 0.09–0.87
TTC (median, range) 47.5 (25–92) 35.0 (14–136) 0.007
30-day mortality 1 (2.4%) 2 (2.4%) -
90-day mortality 8 (19.1%) 6 (7.1%) 0.061

B.
Factor Stoma (n=9) No stoma (n=75) P-value#

LOS in days (median, range) 11 (7.3) 9 (6.0) 0.26
Unplanned ICU admission 3 (33.3%) 7 (9.3%) 0.07
Ability to start chemotherapy 8/8 (100%) 61/67 (91%) 1.00
TTC (median, range) 36.5 (30–54) 34 (14–136) 0.29
30-day mortality 0 (0%) 2 (2.7%) 1.00
90-day mortality 1 (11.1%) 5 (6.8%) 0.51
*

P-value from stratified conditional logistic regression models

Hospital length of stay (LOS); time to chemotherapy (TTC)

Too few events to compare

#

Continuous variables: Wilcoxon rank sum test; categorical variables: Chi-square test